FALL 2021, THE EVIDENCE FORUM, WHITE PAPER
 Donald Smith, PhD Senior Scientific Director Evidence Synthesis, Modeling & Communication Evidera, a PPD business |  Naomi Stapleton, BS Associate Director Evidence Synthesis, Modeling & Communication Evidera, a PPD business |  Leslee Masten, BA Principal Market Access Writer Evidence Synthesis, Modeling & Communication Evidera, a PPD business |
The use of streamlined, pharmaceutical product global value dossiers (called “mini-GVDs”) has increased in the last two years. Mini-GVDs come in a variety of formats, can be useful in a number of different situations, and can be created prior to, near, or after product launch. This article will describe mini-GVDs, some of their potential uses, and also several benefits that they can provide to our clients and their affiliates.
Download White Paper
Fill out the form below to download this whitepaper.
